C

Crinetics Pharmaceuticals
D

CRNX

40.880
USD
-0.62
(-1.49%)
مغلق
حجم التداول
56,750
الربح لكل سهم
-5
العائد الربحي
-
P/E
-10
حجم السوق
3,849,914,635
أصول ذات صلة الأخبار المقالات

العنوان: Crinetics Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.